Sun Pharma to acquire 16.33 pc stake in US-based Surgimatix
Sun Pharma on Tuesday said that it has decided to acquire a 16.33% stake in the US-based Surgimatix for US$ 3.05 million.
Sun Pharma FY24 Sept qtr net profit grows 5% to Rs 2,376 cr
Mumbai: Leading pharma company Sun Pharmaceutical Industries Ltd Wednesday reported a 5% increase in its net profit for the July-September quarter, reaching Rs 2,375.5 crore compared to Rs 2,262.2 crore in the corresponding period last year.
Sun Pharma drops 3.11 per cent to Rs 860.45
Mumbai: Sun Pharma on Tuesday slid 3.11 per cent to Rs 860.45 a major loser in 30 scrips of BSE.
Sun Pharma moves up 3.99 pc to touch Rs 855.55
Mumbai/UNI/IBNS: Sun Pharma on Tuesday rose 3.99 per cent to Rs 855.55, a major gainer in 30 scrips of the BSE.
Sun Pharma moves down by 3.06 pc to Rs 789.70
Mumbai/UNI: Sun Pharma on Wednesday tumbled down by 3.06 pc to Rs 789.70 a major loser in 30 scrips of BSE.
Sun Pharma moves up by 5.51 pc to Rs 539.75
Mumbai/UNI: Sun Pharma on Tuesday surged by 5.51 pc to Rs 539.75 a major gainer in 30 scrips of BSE.
Mumbai/UNI: Sun Pharma on Monday tumbled down by 7.34 per cent to Rs 515 a major loser in 30 scrips of BSE while ONGC by 1.74 per cent was the top gainer.
Sun Pharma Q1 consolidated loss at Rs 1655.60 cr
Mumbai, Jul 31 (UNI) Pharma major, Sun Pharma reported a net loss of Rs 1655.60 crores for the quarter ended June 30, 2020 as against net profit of Rs.1387.48 crores for the quarter ended June 30.
Sun Pharma rallied by 6.64 pc to Rs 393.35
Mumbai/UNI: Sun Pharma on Tuesday advanced by 6.64 per cent to Rs 393.35 to be the top gainers in the 30 scrips index of Bombay Stock Exchange (BSE).
Sun Pharma moves down by 4.23 pc to Rs 421.80
Mumbai,/UNI: Sun Pharma on Friday slipped by 4.23 pc to Rs 421.80 to be the top loser in the 30 scrips index of Bombay Stock Exchange (BSE).